Thanks for pointing out ohm that dated terms are important in such agreements. Surely CytoDyn would avoid or at least provide a Nader cushion of 300+% for any such trigger given his and FDA delays to date.....not to mention any external BP or RP incentivizing pressure against the company.

Time will tell, but I’d be shocked if we have been able to walk from Vancouver, WA to see the magnificent Grand Canyon to simply trip and fall into it by tripping over a pebble after exhaustion at this point. NP is too dedicated and determined to fail this close to the finish line. Although the share price doesn’t say such, I’m waiting on someone to discredit the science behind leronlimab to shake my confidence.....nothing even close yet....it’s actually gaining steam!